baber/WOPTO huggingface dataset:
Patent DK-2699681-T3 (DK)
Inventor: TAKKINEN KRISTIINA
IPC: C12N15/29
Filed: 2012-04-18
Granted: 2018-08-13
Abstract: The present invention provides mutant polypeptides useful as hypoallergens. More specifically the present invention provides mutant Bet v 1 proteins and the use of such polypeptides as hypoallergens for desensitizing against birch pollen allergies. Furthermore, the invention provides vaccine formulations comprising such polypeptides; the use of such formulations; and to methods of vaccination against birch pollen allergy.
Patent DK-3080504-T3 (DK)
Inventor: NICOLAS YANN
IPC: G01M3/40
Filed: 2014-12-11
Granted: 2018-01-02
Abstract: The invention relates to an end-piece (14) which comprises: an end region (33) of a layer to be monitored (26) of the flexible pipe, the end region (33) being at least partially made of metal; an end segment (32) of a pressure sheath (20) of the flexible pipe (10); an end high point (50) and a cover (51) fastened onto the end high point (50), the end high point (50) and the cover (51) defining a chamber (52) therebetween. The end-piece (14) comprises a sensor (58) for detecting the position of the layer to be monitored (26), capable of detecting an axial movement of the end region (33), the sensor (58) being arranged outside the end segment (32) of the pressure sheath (20) and outside of the end high point (50).
Patent DK-0382075-T3 (DK)
Inventor: JANSSEN BERND DR
IPC: A61K8/30
Filed: 1990-02-01
Granted: 1994-05-24
Abstract: Phenylhydrazones of  beta -ionone, of the formula I 
<IMAGE>
 in which R assumes the meaning given in the description, and their preparation are described. The substances are suitable for controlling diseases and as cosmetic agents.
Patent DK-0406035-T3 (DK)
Inventor: BREANT PATRICE
IPC: C08K3/22
Filed: 1990-05-21
Granted: 1994-08-22
Abstract: Flame-retarded polymer compositions comprising a hydrated inorganic filler, at least one ethylene/alkyl (meth)acrylate copolymer and at least one copolymer of ethylene and of at least one  alpha -olefin, which compositions consist essentially of 120 to 240 parts by weight of hydrated inorganic filler per 100 parts by weight of a polymer phase consisting of: (a) 30 to 75 parts by weight of at least one ethylene/alkyl (meth)acrylate copolymer (A) having a content of alkyl (meth)acrylate of between 1 and 50 mol %, (b) 10 to 30 parts by weight of at least one ethylene/alkyl (meth)acrylate/unsaturated dicarboxylic acid anhydride terpolymer (B), (c) 5 to 55 parts by weight of at least one copolymer of ethylene and of at least one alpha -olefin (C) having a density of between 0.865 and 0.915 and a degree of crystallinity equal to at least 5%, and (d) 0 to 5 parts by weight of at least one low-density polyethylene (D). Industrial articles comprising such a flame-retarded polymer composition.
Patent DK-0470317-T3 (DK)
Inventor: GUILLONNEAU CLAUDE
IPC: A61K31/52
Filed: 1990-09-17
Granted: 1994-09-19
Abstract: Use, for obtaining medications intended for the treatment of memory disorders, intellectual disorders of senility and Alzheimer's disease, of 1,3,7-trimethyl-8-[4-(diethylaminocarbonyl-3-piperazinopropyl] xanthine and of its physiologically tolerable acid addition salts.
Patent DK-0451612-T3 (DK)
Inventor: LINSLEY PETER S
IPC: C12N15/09
Filed: 1991-03-26
Granted: 1997-06-16
Abstract: The present invention relates to monoclonal antibodies that define Oncostatin M. The monoclonal antibodies of the invention are capable of binding to Oncostatin M, inhibiting Oncostatin M receptor binding, and/or inhibiting Oncostatin M bioactivity. Such antibodies may be used to detect the presence of Oncostatin M and/or to modulate Oncostatin M bioactivities in an in vivo or in vitro system.
Patent DK-0486158-T3 (DK)
Inventor: SCHMALZ A CHANDLER
IPC: D04H1/42
Filed: 1991-10-16
Granted: 1996-10-21
Abstract: An improved method for producing hydrophobic polyolefin-containing staple fiber for processing, with reduced waste and improved crimp by sequential treatment with two finish compositions comprising at least one neutralized phosphoric acid ester and at least one polysiloxane of defined classes and amounts.
Patent DK-0544713-T3 (DK)
Inventor: ANDERSON KEVIN P
IPC: A61P31/12
Filed: 1991-08-14
Granted: 1997-09-29
Abstract: PCT No. PCT/US91/05815 Sec. 371 Date Nov. 19, 1992 Sec. 102(e) Date Nov. 19, 1992 PCT Filed Aug. 14, 1991Compositions and methods for modulating the effects of cytomegalovirus (CMV) infections are disclosed, comprising contacting CMV mRNA with an oligonucleotide or oligonucleotide analog which can bind with at least portions of the CMV RNA. In accordance with the preferred embodiments, oligonucleotides or oligonucleotide analogs are designed to bind with portions of the CMV mRNAs which code for the IE1, IE2 or DNA polymerase proteins. In accordance with a preferred embodiment, methods of treatment of human cytomegalovirus are disclosed.
Patent DK-0555259-T3 (DK)
Inventor: MIETH HANS OTTO
IPC: F16K1/44
Filed: 1991-10-18
Granted: 1996-05-20
Abstract: PCT No. PCT/EP91/01984 Sec. 371 Date Apr. 30, 1993 Sec. 102(e) Date Apr. 30, 1993 PCT Filed Oct. 10, 1991 PCT Pub. No. WO92/08070 PCT Pub. Date May 14, 1992.A process for cleaning the seats of a double seat valve having two independently movable closing elements, each of the closing elements being associated with a respective one of the valve seats, which closing elements can be moved into simultaneous fully open positions when the double seat valve is in an open state, and at least one of the closing elements is movable to a partly open position independently of the other closing element, in which partly open position a passage is defined between said at least one closing element and the seat associated with said at least one closing element, comprising: periodically alternately moving said at least one closing element to the partly open position and reversing the moving to move said at least one closing element to the closed position in partial stroke movements, the reversing of partial stroke movements of the closing elements from opening to closing movement and from closing to opening movement is done by a control unit in response to the passage of time, to the closing elements attaining predetermined positions, or as a function of the flow of cleaning agent.
Patent DK-0522341-T3 (DK)
Inventor: VOIGT REINER DIPL-ING
IPC: A61K6/896
Filed: 1992-06-22
Granted: 1997-05-26
Abstract: The present invention relates to a transparent material based on addition-crosslinking polysiloxanes, which is preferably used for bite registration in dentistry.
Patent DK-0500445-T3 (DK)
Inventor: BALIAN PIERRE
IPC: C03C27/06
Filed: 1992-02-18
Granted: 1996-09-16
Abstract: Product comprising a glass substrate and a transparent conductive layer of "substoichiometric" metal oxide coated with an overlayer of metal oxide protecting the conductive oxidation layer. The refractive indices of the two layers and the geometrical thickness of the overlayer can be additionally selected so as to offer a product which is neutral in reflection. The invention also relates to the processes for obtaining the said product.
Patent DK-0507697-T3 (DK)
Inventor: BERGMANN CLAUDE
IPC: H02M7/5387
Filed: 1992-04-03
Granted: 1996-08-05
Abstract: Control device for an electric motor with stator winding, in particular an asynchronous motor. A DC voltage (12) is chopped by means of variable frequency and variable mark/space ratio switches (151, 181) in such a way that in each chopping period the intensity of the stator current is dependent on the mark/space ratio. A generator (20) is provided so that this mark/space ratio varies sinusoidally. The chopping frequency is variable in order to permit frequency variation of the sinusoid and hence speed variation of the motor. <IMAGE>
Patent DK-0531246-T3 (DK)
Inventor: LEMMING MICHAEL
IPC: E05F1/02
Filed: 1992-08-26
Granted: 1996-03-18
Abstract: In a braking device for self-closing doors of the type in which the closing movement is activated by means of a drop plumb (1) which via an elongated flexible transmission element (7) such as a pull wire can engage an element connected to the upper edge of the door, the transmission element (7) is routed mainly slip free over a transmission wheel (6), connected directly to the drop plumb and connected to an automatic revolving braking device, such as an eddy-current brake. <IMAGE>
Patent DK-0665742-T3 (DK)
Inventor: MATHUR RAJIV
IPC: A61Q19/08
Filed: 1992-08-20
Granted: 2001-04-09
Abstract: A new class of lipid vesicles having a blend of two lipids, a primary lipid and a secondary lipid, has been developed. The primary lipid, which forms the greatest proportion of lipid by weight, will not form vesicles nor preferably, even a lamellar phase, without addition of the secondary lipid. Preferably primary lipids are C12-C18 fatty alcohols, C12-C18 glycol monoesters, and C12-C18 glyceryl mono- and diesters.
Patent DK-0574174-T3 (DK)
Inventor: MARSHALL WINSTON STANLEY
IPC: A61K31/40
Filed: 1993-06-02
Granted: 2003-12-08
Abstract: This invention provides pharmaceutical heterocyclic derivatives of the formula <CHEM>  in which R3 are specified nitrogen-containing fused rings. They antagonize angiotensin II receptors in mammals.
Patent DK-0570326-T3 (DK)
Inventor: CAMPAU DANIEL N
IPC: G05D11/00
Filed: 1993-05-11
Granted: 1997-07-21
Abstract: An apparatus (10) and method are disclosed for dispensing a first liquid (26) into a second reservoir liquid (30). The apparatus comprises a container (12) adapted to hold the dispensable liquid, a dispensing nozzle (14) and a sensing tube (18). The dispensing nozzle is positioned on the container below the dispensable liquid level (28) within the container. The sensing tube has first (20) and second (22) open ends, the first open end positioned above the dispensable liquid level within the container and the second open end positioned outside the container and below the dispensing nozzle. The second open end of the sensing tube is immersible in the reservoir liquid, whereby the cyclic fall and rise of the reservoir liquid results in the controlled discharge of the dispensable liquid from the container through the dispensing nozzle. The method comprises the steps of providing a container as described above, locating the container above the reservoir liquid, and causing the reservoir liquid to rise and fall to discharge the dispensable liquid from the dispensing nozzle. <IMAGE>
Patent DK-0653926-T3 (DK)
Inventor: SILVESTRINI THOMAS A
IPC: A61F9/00
Filed: 1993-08-04
Granted: 1999-11-01
Abstract: This invention is an intrastromal corneal ring having comprising at least one outer layer of a physiologically compatible polymer having a low modulus of elasticity, which polymer may be hydratable and may be hydrophilic. The inner portion of the hybrid intrastromal corneal ring may be hollow or may contain one or more physiologically compatible polymers.
Patent DK-0675834-T3 (DK)
Inventor: BANKS STEWART
IPC: B65D75/58
Filed: 1994-01-04
Granted: 1997-04-14
Abstract: A pliable, fluid dispensing pouch is provided which includes a flexible shot-chamber having at least two narrow spaced tortuous fluid pathways each leading to a separate discharge opening at one end of the pouch. The discharge openings are initially sealed closed by the presence of a sealing tab. The discharge openings are unsealed by tearing off the tab. The separate discharge openings are of a diameter suitable to prevent fluid from being hand or finger squeezed out of the pouch once the tear tab has been detached.
Patent DK-0682023-T3 (DK)
Inventor: NARITA HIROSHI
IPC: C07D471/04
Filed: 1995-04-18
Granted: 1997-03-17
Abstract: An imidazopyridine derivative of the formula [I]: <CHEM> wherein R<1> is a lower alkyl group, R<2> is a lower alkanoyl group, and R<3> and R<4> are each lower alkyl groups, or both combine at the end thereof to form an alkylene group having 3 to 6 carbon atoms, and a pharmaceutically acceptable salt thereof, said imidazopyridine derivatives have an excellent angiotensin II antagonistic activity and are useful for the prophylaxis or treatment of hypertension.
Patent DK-0699768-T3 (DK)
Inventor: FISHER MARY ELLEN
IPC: C12Q1/6823
Filed: 1995-08-18
Granted: 2003-10-20
Abstract: Method for controlling the light emission of a single-stranded oligonucleotide covalently labelled with a light-emitting label comprises adding a DNA-binding cpd. to a soln. of the labelled oligonucleotide, where the DNA-binding cpd. is capable of interacting with the label to modify its light emission. Also claimed are: (1) a method for detecting cleavage of a labelled oligonucleotide and (2) a method for detecting a target nucleic acid sequence in a sample, comprising measuring the light emission of a PCR mixt.
Patent DK-0789643-T3 (DK)
Inventor: TAPOJAERVI EERO
IPC: E04C3/14
Filed: 1995-10-31
Granted: 2000-10-09
Abstract: PCT No. PCT/FI95/00600 Sec. 371 Date Jun. 16, 1997 Sec. 102(e) Date Jun. 16, 1997 PCT Filed Oct. 31, 1995 PCT Pub. No. WO96/13361 PCT Pub. Date May 9, 1996The invention relates to a joint arrangement in connection with the manufacture of a wood element blank, especially a wood board blank or a wood beam blank, in which arrangement the wood element blank is arranged to be formed of several blank battens (1-4) that are arranged to be interconnected with an adhesive, whereupon each blank batten (1-4) is formed to have at least partly substantially triangular cross section, so that it may rest on at least four adjacent blank battens, and that the apex of the triangular part of each blank batten (1-4) remains inside the wood element blank. In order to improve the yield and the strength properties, each blank batten (1-4) is formed with substantially radial cleavings, so that the pith of the wood remains at the apex of the triangular part of the blank batten.
Patent DK-0796240-T3 (DK)
Inventor: BYK GERARDO
IPC: A61K47/48
Filed: 1995-12-04
Granted: 2001-05-07
Abstract: PCT No. PCT/FR95/01595 Sec. 371 Date Jun. 4, 1997 Sec. 102(e) Date Jun. 4, 1997 PCT Filed Dec. 4, 1995 PCT Pub. No. WO96/17823 PCT Pub. Date Jun. 13, 1996Cationic lipids of general formula (I), wherein m is an integer from 2 to 6 inclusive; n is an integer from 1 to 9 inclusive, preferably 1-5, where, when n is 2-9, a single R grouping other than hydrogen is present in the general formula, and m has variable or identical values within the groupings (a) or -(CH2)m; R is a hydrogen atom or a radical of general formula (II), wherein X or X1, which are the same or different, are an oxygen atom, a methylene grouping -(CH2)q- where q is 0, 1, 2 or 3, or an amino grouping -NH- or NR1-, where R is a C1-4 alkyl grouping; Y and Y1, which are the same or different, are a hydrogen atom or an optionally substituted C1-4 alkyl radical, and p is 0-5; and R6 is a cholesterol derivative or an alkylamino grouping -NR1R2, where R1 and R2 are, independently of each other, a straight or branched, saturated or unsaturated C12-22 aliphatic radical. Pharmaceutical compositions containing said lipids, and their uses for transfecting nucleic acids whether in vitro or in vivo in cells, are also disclosed.
Patent DK-0745387-T3 (DK)
Inventor: HJORTH RICHARD NORMAN
IPC: A61K39/145
Filed: 1996-05-29
Granted: 2005-02-21
Abstract: The present invention discloses mammalian vaccine compositions having an effective amount of an adjuvant, the adjuvant comprising squalene or squlane, glycerol and a surfactant. These compositions also optionally contain an aluminium salt and one or more pharmaceutically acceptable buffers.
Patent DK-0743257-T3 (DK)
Inventor: CARTIER NOEL
IPC: D21H27/32
Filed: 1996-05-06
Granted: 2000-05-08
Abstract: A container, consisting of molded, greaseproof and especially sulfurized paper, is new. A container, especially a small tray for holding products, consists of a single or multilayer sheet of molded, greaseproof and especially sulfurized paper of 25-250 g/m<2> weight. An Independent claim is also included for production of the above container by subjecting the paper sheet described above to moistening to 10-30 % moisture content to increase its pliability and elasticity and then molding to container shape by edge grooving and folding or by hot forming with heated punches and dies.
Patent DK-0842178-T3 (DK)
Inventor: ELLIOTT RICHARD L
IPC: A61P9/00
Filed: 1996-07-25
Granted: 2001-08-06
Abstract: Novel heterocyclic ether compounds having the formula: wherein A, m, R, X, Y1, Y2 and Y3 are specifically defined, which are useful in selectively controlling chemical synaptic transmission; therapeutically-effective pharmaceutical compositions thereof; and use of said compositions to selectively control synaptic transmission in mammals.
Patent DK-0910405-T3 (DK)
Inventor: DOUVAS ANGELINE
IPC: C12Q1/68
Filed: 1997-03-14
Granted: 2002-02-18
Abstract: The present invention provides a vaccine comprising a caprine arthritis-encephalitis virus (CAEV) immunogen and a pharmaceutically acceptable carrier. The invention also provides a method of stimulating an immune response in an individual against human immunodeficiency virus-1 infection or against CAEV infection by administering a therapeutically effective amount of a CAEV immunogen to the individual. The invention further provides a method of stimulating an immune response in vitro by contacting a lymphocyte with a therapeutically effective amount of a CAEV immunogen. Methods of diagnosing CAEV infection in humans are also provided.
Patent DK-0959895-T3 (DK)
Inventor: CASSELS FREDERICK
IPC: C07K7/08
Filed: 1997-08-01
Granted: 2004-12-20
Abstract: This invention relates to amino acid sequences from within a consensus peptide of the formula: VEKNITVTASVDPTIDLLQADGSALPSAVALTYSPA (Seq. #1). Eight mer peptides from within the consensus peptide were tested against an antibody raised to the consensus peptide. Studies relating to antibody raised to denatured proteins from the natural organisms producing the family of proteins were also useful and showed particular value of some sequences. A sequence of the formula ASVDPTIDLLQA (Seq. #2) was identified thereby. An enlarged sequence of the formula TVTASVDPTIDLLQAD (Seq. #3) is also especially interesting as are intermediate sequences such as sequences VTASVDPTIDLLQAD (Seq. #4), TASVDPTIDLLQAD (Seq. #5), and TASVDPTIDLLQA (Seq. #6) as being binding sites for antibodies raised to the denatured proteins.
Patent DK-0988533-T3 (DK)
Inventor: PETERSON IAN ROBERT
IPC: G01N27/333
Filed: 1998-06-15
Granted: 2003-07-07
Abstract: A biosensor has a lipid membrane (7) containing gated ion channels sensitive to the presence or otherwise of an analyte molecule in a sample applied, in use, to a first side of the lipid membrane (7). The lipid membrane (7) is disposed between a pair of electrodes (1, 2) in which a first layer of porous gel (4) is applied to the first side of the lipid membrane (7).
Patent DK-1023308-T3 (DK)
Inventor: SCHRAMM VERN L
IPC: A01N43/04
Filed: 1998-10-14
Granted: 2006-01-23
Abstract: The present invention provides compounds having the formula: wherein A is CH or N; B is chosen from OH, NH<SUB>2</SUB>, NHR, H or halogen; D is chosen from OH, NH<SUB>2</SUB>, NHR, H, halogen or SCH<SUB>3</SUB>; R is an optionally substituted alkyl, aralkyl or aryl group; and X and Y are independently selected from H, OH or halogen except that when one of X and Y is hydroxy or halogen, the other is hydrogen; and Z is OH or, when X is hydroxy, Z is selected from hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted alkyl, aralkyl or aryl group; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof; and compounds having the formula: wherein A, X, Y, Z and R are defined for compounds of formula (I) where first shown above; E is chosen from CO<SUB>2</SUB>H or a corresponding salt form, CO<SUB>2</SUB>R, CN, CONH<SUB>2</SUB>, CONHR or CONR<SUB>2</SUB>; and G is chosen from NH<SUB>2</SUB>, NHCOR, NHCONHR or NHCSNHR; or a tautomer thereof, or a pharmaceutically acceptable salt thereof, or an ester thereof, or a prodrug thereof. The present invention also provides the use of the above compounds as pharmaceuticals, pharmaceutical compositions containing the compounds and processes for preparing the compounds.
Patent DK-0940424-T3 (DK)
Inventor: KLEINKNECHT HARALD
IPC: C08J3/22
Filed: 1999-02-20
Granted: 2002-12-09
Abstract: The production of a polymer master batch (I) containing short fibers or pulp comprises: (1) dispersion in water of fibers up to 20 mm long in a 3-20 fold excess by weight; (2) addition of a reaction component of the polymer to be produced to the dispersion with stirring; (3) mechanical removal of the water (4) drying of the fiber/reaction component mixture; and (5) optionally adding other reaction components followed by polymerisation to form (I).
Patent DK-1094804-T3 (DK)
Inventor: ANGELLO JAMES T
IPC: A61P25/04
Filed: 1999-07-08
Granted: 2006-02-06
Abstract: The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid to relieve the pain associated with renal colic.
Patent DK-1103104-T3 (DK)
Inventor: GUNZELMANN BERTRAM
IPC: H04B1/707
Filed: 1999-07-01
Granted: 2003-05-05
Abstract: An acquisition method for identifying a transmitter, and a correlator for carrying out the method includes correlating a received binary-coded spread sequence having m bits at a frequency f with a locally generated spread sequence by phase-shifting a multiplicity of locally generated spread sequences with respect to the received spread sequence, where f is the frequency of the incoming spread sequence. The received spread sequence is correlated with a locally generated spread sequence at the frequency f. The received spread sequence is stored and the stored, received spread sequence is processed at an oversampling rate i*f. The received, stored spread sequence is split into i sections and the correlation is carried out in i steps.
Patent DK-1137773-T3 (DK)
Inventor: SHEPPARD PAUL O
IPC: A61P35/00
Filed: 1999-12-07
Granted: 2008-12-08
Abstract: Polypeptide growth factors, methods of making them, polynucleotides encoding them, antibodies to them, and methods of using them are disclosed. The polypeptides comprise an amino acid segment that is at least 90% identical to residues 46-163 of SEQ ID NO:2 or residues 235-345 of SEQ ID NO:2. Multimers of the polypeptides are also disclosed. The polypeptides, multimeric proteins, and polynucleotides can be used in the study and regulation of cell and tissue development, as components of cell culture media, and as diagnostic agents.
Patent ES-2226690-T3 (ES)
Inventor: SCHOENIG HELGE
IPC: E06B3/02
Filed: 2000-11-24
Granted: 2005-04-01
Abstract: Spacers (26) are inserted between the spaced panes (12, 14) and each have round the edge a socket for each pane. At least one of the edge sockets can be formed as a screw-in part (44,50) which screws into the spacer. One screw-in part (44) has a right-hand thread on its outside and a left- hand thread (46) on its inside whilst the other screw-in part (50) has a left-hand thread on its outside for screwing into the first screw part.